Bioxytran (BIXT) EBT Margin Growth (1y) (2011 - 2018)
Bioxytran (BIXT) EBT Margin Growth (1y) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 546.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4,709.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,076.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,911.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2,507.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,565.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -392.00 |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 65,840.00 |
| Mar 31, 2018 | 86,353.00 |
| Dec 31, 2017 | -50,226.00 |
| Sep 30, 2017 | 25,697.00 |
| Jun 30, 2017 | -39,851.00 |
| Mar 31, 2017 | 57,487.00 |
| Dec 31, 2016 | 21,685.00 |
| Sep 30, 2016 | -39,776.00 |
| Jun 30, 2016 | 296,436.00 |
| Mar 31, 2016 | -138,093.00 |
| Dec 31, 2015 | -193,027.00 |
| Sep 30, 2015 | 287,610.00 |
| Jun 30, 2015 | -307,193.00 |
| Mar 31, 2015 | -9,263.00 |
| Dec 31, 2014 | 200,930.00 |
| Sep 30, 2014 | -219,223.00 |
| Jun 30, 2014 | 49,245.00 |
| Mar 31, 2014 | 88,233.00 |
| Dec 31, 2013 | 106,200.00 |
| Sep 30, 2013 | 441,190.00 |